TLR3 stimulation by Poly I:C or BCG has been implicated in promoting tumor cell death in a multitude of cancers, including breast cancer, colon cancer, bladder cancer, head and neck carcinoma, pharynx carcinoma, hepatocellular carcinoma, lung cancer and melanoma. The gene discussed is TLR3; the disease is breast carcinoma.